L&G Pharma Breakthrough UCITS ETF (LON:BIGT)
London · Delayed Price · Currency is GBP · Price in GBX 852.35
-2.50 (-0.29%)
Aug 7, 2025, 4:35 PM BST
-0.29% (1Y)
| Assets | 16.19M |
| Expense Ratio | 0.49% |
| PE Ratio | 15.12 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +6.74% |
| Volume | 9,676 |
| Open | 860.40 |
| Previous Close | 854.85 |
| Day's Range | 852.35 - 860.50 |
| 52-Week Low | 705.20 |
| 52-Week High | 878.04 |
| Beta | 0.44 |
| Holdings | n/a |
| Inception Date | Jan 23, 2018 |
About BIGT
The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.
Asset Class Equity
Category Health Care
Stock Exchange London Stock Exchange
Ticker Symbol BIGT
Provider L&G
Index Tracked Solactive Pharma Breakthrough Value Index
Performance
BIGT had a total return of 6.74% in the past year, including dividends. Since the fund's inception, the average annual return has been -1.93%.